Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model-Reference-Cited by-同舟云学术

Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model

Published:2023-04 Issue: Volume:117 Page:109996
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Ricci Daniela^ORCID,Etna Marilena Paola,Severa Martina^ORCID,Fiore Stefano,Rizzo Fabiana^ORCID,Iannetta Marco,Andreoni Massimo,Balducci Stefano,Stefanelli Paola,Palamara Anna Teresa,Coccia Eliana Marina

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference53 articles.

1. The trinity of COVID-19: immunity, inflammation and intervention;Tay;Nat. Rev. Immunol.,2020

2. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia;De Biasi;Nat. Commun.,2020

3. COVID-19: consider cytokine storm syndromes and immunosuppression;Mehta;Lancet,2020

4. A practical update on the management of patients with COVID-19;Mehta;Clin. Med. (Lond.),2022

5. Host directed therapies: COVID-19 and beyond;Tripathi;Curr Res Pharmacol Drug Discov,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic drug discovery: a case for thymosin alpha-1;Frontiers in Medicine;2024-06-06

2. Functional diversification of innate and inflammatory immune responses mediated by antibody fragment crystallizable activities against SARS-CoV-2;iScience;2024-05

3. From bench to bedside: potential of translational research in COVID-19 and beyond;Briefings in Functional Genomics;2023-11-20

4. Thymosin α1 modulated the immune landscape of COVID-19 patients revealed by single-cell RNA and TCR sequencing;International Immunopharmacology;2023-11

5. Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanisms;Pneumonia;2023-09-25